Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

On 24 September 2016, the Multiple Sclerosis Clinical Trials Unit hosted 102 patients and family members/carers at the Unipart Conference Centre in Oxford.

In the morning Dr Matthew Craner updated everyone on the topics presented at a recent MS conference and Dr Jacqueline Palace talked about the UK Risk Sharing Scheme, which helped make second-line treatments more available for patients with MS.

Fascinating set of presentations. Complicated sciences presented in an accessible and interesting way. Well done to all.
- Patient attendee

Several early-career researchers then presented the projects they are currently working on in the field of MS. During lunch there were posters from researchers detailing their research as well as an opportunity to get information leaflets from a local MS Society branch and sign up for the brain bank.

In the afternoon three key speakers gave detailed presentations on stem cells (Dr Andrew Weir), using clinical data to improve treatment of MS (Professor Paul Matthews), and genetics (Professor Lars Fugger).

 

Similar stories

Insights into the molecular pathways of progressive multiple sclerosis

Text by Ian Fyfe for 'Nature Reviews Neurology'

Discovery of gene involved in chronic pain creates new treatment target

Our researchers have discovered a gene that regulates pain sensitisation by amplifying pain signals within the spinal cord. This is helping them to understand an important mechanism underlying chronic pain in humans, and provides a new treatment target.

Lymph nodes reveal more about mechanisms of autoimmunity

Two recent papers show that studying lymph nodes reveals details of the mechanisms of autoimmunity.

Multiple heart-related conditions linked to triple dementia risk, regardless of genetics

Having multiple conditions that affect the heart is linked to a greater risk of dementia than having high genetic risk, according to a large-scale new study.

NDCN research presented at Myasthenia Gravis conference

The 14th Quinquennial Myasthenia Gravis Federation of America International Conference was recently held in Miami with 450 delegates attending in person, including over 100 from industry.